News
Endo Pharmaceuticals, Inc. Announces Withdrawal of Opana ER
Endo Pharmaceuticals announced it would be voluntarily withdrawing Opana ER (Oxymorphone ER) from the market….
Excellence in Caring: Denise
I would like to nominate Denise. She was in charge of my DME training. She…
42nd Annual Florida RIMS Educational Conference
Dean Moroney, Account Executive, will be attending the 42nd Annual Florida RIMS Educational Conference July…
Ohio Self Insured Conference
Our National Sales Executive, Dunn Swanson, will be attending the Ohio Self Insured Conference June…
2017 VSIA General Meeting
Janeen Cantillion, Account Executive, will be exhibiting at the 2017 VSIA General Meeting. Come visit…
20th Tennessee Workers’ Compensation Educational Conference
The 20th Tennessee Workers’ Compensation Educational Conference will be hosted on June 13-15 2017, at…
GWCA Spring Conference
John Means, Account Representative, will be attending the 2017 GWCA Spring Conference on Jekyll Island….
26th Annual Workers’ Compensation Seminar
Faye Glass will be attending the 20th Annual Workers’ Compensation Seminar at The Galt House…
Launch of Generic Butrans
The FDA has recently approved the generic equivalent of Butrans (Buprenorphine) transdermal patches. Butrans is…
Launch of Generic Strattera
The generic equivalent of Strattera (Atomoxetine) has just been released, following FDA approval. Strattera is…
